OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

Repligen Corp/  US7599161095  /

IEX
10/4/2024  9:59:59 PM Chg. -2.40 Volume Bid- Ask- Market Capitalization Dividend Y. P/E Ratio
136.69USD -1.73% 48,699
Turnover: 6.7 mill.		 -Bid Size: - -Ask Size: - 7.66 bill.USD - 182.28
GlobeNewswire 8/23 Repligen Corporation to Present at Wells Fargo Healthcare Conference
GlobeNewswire 7/30 Repligen Reports Second Quarter 2024 Financial Results
GlobeNewswire 7/29 Repligen Announces Agreement to Acquire Chromatography Innovator Tantti
GlobeNewswire 7/16 Repligen to Report Second Quarter 2024 Financial Results
GlobeNewswire 6/13 Repligen Announces CEO Transition Plan
GlobeNewswire 5/22 Repligen Corporation to Present at Upcoming June Investor Conferences
GlobeNewswire 5/7 Repligen Corporation to Present at Upcoming May Investor Conferences
GlobeNewswire 5/6 The Benchmark Company Announces Upcoming Healthcare House Call VIRTUAL One-on-One Investor Conferenc...
GlobeNewswire 5/1 Repligen Reports First Quarter 2024 Financial Results
GlobeNewswire 4/17 Repligen to Report First Quarter 2024 Financial Results
GlobeNewswire 3/19 Repligen Appoints Maggie A. Pax to Board of Directors
GlobeNewswire 2/21 Repligen Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire 12/19/2023 Repligen Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire 12/7/2023 Repligen Announces Private Convertible Transaction of $600 Million Principal Amount of 1.00% Convert...
GlobeNewswire 11/14/2023 UPDATE – Repligen Announces Publication of the Company’s 2022 Sustainability Report
GlobeNewswire 11/14/2023 Repligen Announces Publication of the Company’s 2022 Sustainability Report
GlobeNewswire 11/7/2023 Repligen Corporation to Present at Upcoming Investor Conferences
GlobeNewswire 11/2/2023 Repligen Launches TangenX® SC as First-to-Market Holder-Free Self-Contained TFF Device
GlobeNewswire 10/31/2023 Repligen Reports Third Quarter 2023 Financial Results and Updates Full Year 2023 Financial Guidance
GlobeNewswire 10/17/2023 Repligen to Report Third Quarter 2023 Financial Results
GlobeNewswire 10/10/2023 Jonathan Milner issues Open Letter to shareholders of Abcam plc
GlobeNewswire 10/2/2023 Repligen Appoints Olivier Loeillot as President and Chief Commercial Officer
GlobeNewswire 9/26/2023 Repligen Announces Agreement to Acquire Fluid Management Innovator Metenova
GlobeNewswire 9/12/2023 Repligen Appoints Jason K. Garland as Chief Financial Officer
GlobeNewswire 9/1/2023 Repligen Corporation to Present at Wells Fargo Healthcare Conference